These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21981420)

  • 21. The partial positive allosteric GABA(A) receptor modulator EVT 201 is efficacious and safe in the treatment of adult primary insomnia patients.
    Walsh JK; Thacker S; Knowles LJ; Tasker T; Hunneyball IM
    Sleep Med; 2009 Sep; 10(8):859-64. PubMed ID: 19345644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insomnia subtypes and their relationships to daytime sleepiness in patients with obstructive sleep apnea.
    Chung KF
    Respiration; 2005; 72(5):460-5. PubMed ID: 16210883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse childhood experiences associated with sleep in primary insomnia.
    Bader K; Schäfer V; Schenkel M; Nissen L; Schwander J
    J Sleep Res; 2007 Sep; 16(3):285-96. PubMed ID: 17716278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heart rate and heart rate variability in subjectively reported insomnia.
    Spiegelhalder K; Fuchs L; Ladwig J; Kyle SD; Nissen C; Voderholzer U; Feige B; Riemann D
    J Sleep Res; 2011 Mar; 20(1 Pt 2):137-45. PubMed ID: 20626615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired declarative memory consolidation during sleep in patients with primary insomnia: Influence of sleep architecture and nocturnal cortisol release.
    Backhaus J; Junghanns K; Born J; Hohaus K; Faasch F; Hohagen F
    Biol Psychiatry; 2006 Dec; 60(12):1324-30. PubMed ID: 16876140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discontinuation of hypnotics during cognitive behavioural therapy for insomnia.
    Zavesicka L; Brunovsky M; Matousek M; Sos P
    BMC Psychiatry; 2008 Sep; 8():80. PubMed ID: 18801160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insomnia and the eye of the beholder: are there clinical markers of objective sleep disturbances among adults with and without insomnia complaints?
    Edinger JD; Fins AI; Glenn DM; Sullivan RJ; Bastian LA; Marsh GR; Dailey D; Hope TV; Young M; Shaw E; Vasilas D
    J Consult Clin Psychol; 2000 Aug; 68(4):586-93. PubMed ID: 10965634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spontaneous K-complexes in chronic psychophysiological insomnia.
    Bastien CH; St-Jean G; Turcotte I; Morin CM; Lavallée M; Carrier J; Forget D
    J Psychosom Res; 2009 Aug; 67(2):117-25. PubMed ID: 19616138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of temazepam 7.5 mg and temazepam 15 mg on sleep maintenance and sleep architecture in a model of transient insomnia.
    Erman MK; Loewy DB; Scharf MB
    Curr Med Res Opin; 2005 Feb; 21(2):223-30. PubMed ID: 15801993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pretherapy cognitive dispositions and treatment outcome in cognitive behavior therapy for insomnia.
    Edinger JD; Carney CE; Wohlgemuth WK
    Behav Ther; 2008 Dec; 39(4):406-16. PubMed ID: 19027437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of cognitive behavioural therapy for insomnia on sleep architecture and sleep EEG power spectra in psychophysiological insomnia.
    Cervena K; Dauvilliers Y; Espa F; Touchon J; Matousek M; Billiard M; Besset A
    J Sleep Res; 2004 Dec; 13(4):385-93. PubMed ID: 15560773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Global sleep dissatisfaction for the assessment of insomnia severity in the general population of Portugal.
    Ohayon MM; Paiva T
    Sleep Med; 2005 Sep; 6(5):435-41. PubMed ID: 16085459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A polysomnography study of eszopiclone in elderly patients with insomnia.
    McCall WV; Erman M; Krystal AD; Rosenberg R; Scharf M; Zammit GK; Wessel T
    Curr Med Res Opin; 2006 Sep; 22(9):1633-42. PubMed ID: 16968566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sleep perception in insomniacs, sleep-disordered breathing patients, and healthy volunteers--an important biologic parameter of sleep.
    Pinto LR; Pinto MC; Goulart LI; Truksinas E; Rossi MV; Morin CM; Tufik S
    Sleep Med; 2009 Sep; 10(8):865-8. PubMed ID: 19179110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No pain, no gain: an exploratory within-subjects mixed-methods evaluation of the patient experience of sleep restriction therapy (SRT) for insomnia.
    Kyle SD; Morgan K; Spiegelhalder K; Espie CA
    Sleep Med; 2011 Sep; 12(8):735-47. PubMed ID: 21907616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Influence of depressive history on biological parameters in major depression].
    Van Wijnendaele R; Hubain P; Dramaix M; Mendlewicz J; Linkowski P
    Encephale; 2002; 28(1):51-8. PubMed ID: 11963343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of temperament and character on the efficacy of nonpharmacologic treatment of primary insomnia.
    An H; Park J; Jang ES; Chung S
    Compr Psychiatry; 2012 Feb; 53(2):201-7. PubMed ID: 21489422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intensive Sleep Retraining treatment for chronic primary insomnia: a preliminary investigation.
    Harris J; Lack L; Wright H; Gradisar M; Brooks A
    J Sleep Res; 2007 Sep; 16(3):276-84. PubMed ID: 17716277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insomnia and sleep duration in a large cohort of patients with major depressive disorder and anxiety disorders.
    van Mill JG; Hoogendijk WJ; Vogelzangs N; van Dyck R; Penninx BW
    J Clin Psychiatry; 2010 Mar; 71(3):239-46. PubMed ID: 20331928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positive sleep state misperception - a new concept of sleep misperception.
    Trajanovic NN; Radivojevic V; Kaushansky Y; Shapiro CM
    Sleep Med; 2007 Mar; 8(2):111-8. PubMed ID: 17275407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.